298 related articles for article (PubMed ID: 12435384)
1. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
[TBL] [Abstract][Full Text] [Related]
5. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.
García-Martín E; Martínez C; Ladero JM; Agúndez JA
Mol Diagn Ther; 2006; 10(1):29-40. PubMed ID: 16646575
[TBL] [Abstract][Full Text] [Related]
6. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
7. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.
Martínez C; García-Martín E; Blanco G; Gamito FJ; Ladero JM; Agúndez JA
Br J Clin Pharmacol; 2005 Jan; 59(1):62-9. PubMed ID: 15606441
[TBL] [Abstract][Full Text] [Related]
8. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
Topić E; Stefanović M; Samardzija M
Clin Chem Lab Med; 2004 Jan; 42(1):72-8. PubMed ID: 15061384
[TBL] [Abstract][Full Text] [Related]
9. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
[TBL] [Abstract][Full Text] [Related]
10. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
[TBL] [Abstract][Full Text] [Related]
11. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
[TBL] [Abstract][Full Text] [Related]
12. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
[TBL] [Abstract][Full Text] [Related]
14. Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
Yasar U; Bennet AM; Eliasson E; Lundgren S; Wiman B; De Faire U; Rane A
Pharmacogenetics; 2003 Dec; 13(12):715-20. PubMed ID: 14646690
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
Zand N; Tajik N; Moghaddam AS; Milanian I
Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
[TBL] [Abstract][Full Text] [Related]
17. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
[TBL] [Abstract][Full Text] [Related]
18. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
[TBL] [Abstract][Full Text] [Related]
19. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
